TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...
FDA denies exemption request for radiology AI devices, requiring continued 510(k) premarket review to ensure safety and effectiveness.
On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...
A joystick-like robot lets Emory doctors guide a tiny wire to blocked blood vessels, offering precise, minimally invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results